Incyte: RBC raises target price to $114 from $109
INCY•RBC raised its target price on Incyte to $114 from $109.
Related News
Willdan Group: Clear Street raises target price to $145 from $135
WLDN•
Teva wins FDA approval for monthly schizophrenia injection Weltruza
TEVA•
eGain sets agenda, speaker lineup for Solve26 AI, customer experience conference
EGAN•
Avient names Mike Frank CEO, Richard Fearon becomes non-executive chairman
AVNT•
Delta Air cuts profit forecast as $6 billion fuel-cost surge outweighs fare gains
DAL•